Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study

PURPOSE: The BILCAP study described a modest benefit for capecitabine as adjuvant therapy for curatively resected biliary tract cancer (BTC), and capecitabine has become the standard of care. We present the long-term data and novel exploratory subgroup analyses. METHODS: This randomized, controlled,...

Full description

Bibliographic Details
Main Authors: Anthony, A. (Author), BILCAP study group (Author), Bridgewater, J. (Author), Corrie, P. (Author), Cunningham, D. (Author), Davidson, B. (Author), Evans, T.R (Author), Falk, S. (Author), Finch-Jones, M. (Author), Fletcher, P. (Author), Garden, O.J (Author), Iveson, T. (Author), Ma, Y.T (Author), Malik, H.Z (Author), Mirza, D. (Author), Neoptolemos, J. (Author), Palmer, D.H (Author), Prasad, R. (Author), Praseedom, R. (Author), Primrose, J. (Author), Ross, P. (Author), Stocken, D. (Author), Stubbs, C. (Author), Valle, J.W (Author), Wadsley, J. (Author), Wall, L. (Author), Wasan, H. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items